Published in Neuroimage on January 22, 2010
Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications. Nat Rev Neurosci (2011) 4.88
Abnormal structure of frontostriatal brain systems is associated with aspects of impulsivity and compulsivity in cocaine dependence. Brain (2011) 2.00
False positives in neuroimaging genetics using voxel-based morphometry data. Neuroimage (2010) 1.39
Interoception and drug addiction. Neuropharmacology (2013) 1.30
Gray-matter volume in methamphetamine dependence: cigarette smoking and changes with abstinence from methamphetamine. Drug Alcohol Depend (2012) 1.20
Methamphetamine causes persistent immune dysregulation: a cross-species, translational report. Neurotox Res (2010) 1.09
Are there volumetric brain differences associated with the use of cocaine and amphetamine-type stimulants? Neurosci Biobehav Rev (2012) 1.01
Morphometric correlation of impulsivity in medial prefrontal cortex. Brain Topogr (2012) 0.97
Revisiting the role of the insula in addiction. Trends Cogn Sci (2015) 0.96
Insula and orbitofrontal cortical morphology in substance dependence is modulated by sex. AJNR Am J Neuroradiol (2012) 0.94
Levels of neural progenitors in the hippocampus predict memory impairment and relapse to drug seeking as a function of excessive methamphetamine self-administration. Neuropsychopharmacology (2011) 0.93
Reduced insular volume in attention deficit hyperactivity disorder. Psychiatry Res (2012) 0.91
Deficits in cortical, diencephalic and midbrain gray matter in alcoholism measured by VBM: Effects of co-morbid substance abuse. Neuroimage Clin (2013) 0.90
Striatum and insula dysfunction during reinforcement learning differentiates abstinent and relapsed methamphetamine-dependent individuals. Addiction (2013) 0.89
Brain structure links trait creativity to openness to experience. Soc Cogn Affect Neurosci (2014) 0.87
Chronic methamphetamine abuse and corticostriatal deficits revealed by neuroimaging. Brain Res (2014) 0.87
Extended access methamphetamine decreases immature neurons in the hippocampus which results from loss and altered development of neural progenitors without altered dynamics of the S-phase of the cell cycle. Pharmacol Biochem Behav (2011) 0.86
Methamphetamine differentially affects BDNF and cell death factors in anatomically defined regions of the hippocampus. Neuroscience (2014) 0.84
Striatal volume increases in active methamphetamine-dependent individuals and correlation with cognitive performance. Brain Sci (2012) 0.84
Right hemisphere grey matter structure and language outcomes in chronic left hemisphere stroke. Brain (2015) 0.83
Nucleus accumbens invulnerability to methamphetamine neurotoxicity. ILAR J (2011) 0.82
A voxel-based morphometry study of young occasional users of amphetamine-type stimulants and cocaine. Drug Alcohol Depend (2013) 0.82
Brain structure correlates of emotion-based rash impulsivity. Neuroimage (2015) 0.82
Alcohol use disorder with and without stimulant use: brain morphometry and its associations with cigarette smoking, cognition, and inhibitory control. PLoS One (2015) 0.80
Sex differences in impulsivity and brain morphometry in methamphetamine users. Brain Struct Funct (2016) 0.79
Partial MHC/neuroantigen peptide constructs: a potential neuroimmune-based treatment for methamphetamine addiction. PLoS One (2013) 0.78
Gray-matter volume, midbrain dopamine D2/D3 receptors and drug craving in methamphetamine users. Mol Psychiatry (2015) 0.78
Predisposition to and effects of methamphetamine use on the adolescent brain. Mol Psychiatry (2015) 0.78
Low frequency repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex transiently increases cue-induced craving for methamphetamine: a preliminary study. Drug Alcohol Depend (2013) 0.78
Investigating Maternal Brain Structure and its Relationship to Substance Use and Motivational Systems. Yale J Biol Med (2015) 0.78
Functional and structural brain changes associated with methamphetamine abuse. Brain Sci (2012) 0.77
Everyday problems with executive dysfunction and impulsivity in adults recovering from methamphetamine addiction. Addict Disord Their Treat (2016) 0.77
Microstructural changes to the brain of mice after methamphetamine exposure as identified with diffusion tensor imaging. Psychiatry Res (2016) 0.76
Morphometric abnormalities of the lateral ventricles in methamphetamine-dependent subjects. Drug Alcohol Depend (2013) 0.76
Examining brain structures associated with dispositional envy and the mediation role of emotional intelligence. Sci Rep (2017) 0.75
Structural imaging for addiction medicine: From neurostructure to neuroplasticity. Prog Brain Res (2015) 0.75
Neural markers of individual differences in decision-making. Curr Opin Behav Sci (2015) 0.75
The Effect of Chronic Methamphetamine Exposure on the Hippocampal and Olfactory Bulb Neuroproteomes of Rats. PLoS One (2016) 0.75
Plasma Inflammatory Factors Are Associated with Anxiety, Depression, and Cognitive Problems in Adults with and without Methamphetamine Dependence: An Exploratory Protein Array Study. Front Psychiatry (2015) 0.75
Role of microglia in methamphetamine-induced neurotoxicity. Int J Physiol Pathophysiol Pharmacol (2017) 0.75
Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage (2004) 49.54
Fast robust automated brain extraction. Hum Brain Mapp (2002) 41.79
Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage (2002) 38.46
Voxel-based morphometry--the methods. Neuroimage (2000) 34.79
A global optimisation method for robust affine registration of brain images. Med Image Anal (2001) 27.87
Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imaging (2001) 25.22
A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage (2001) 19.86
Commitment, choice and self-control. J Exp Anal Behav (1972) 16.93
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci (2007) 11.24
The neural correlates of subjective value during intertemporal choice. Nat Neurosci (2007) 9.46
Self-control in decision-making involves modulation of the vmPFC valuation system. Science (2009) 8.33
Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage (2002) 8.03
Impulse control in pigeons. J Exp Anal Behav (1974) 7.81
Decision making, impulse control and loss of willpower to resist drugs: a neurocognitive perspective. Nat Neurosci (2005) 7.65
Toward a behavioral economic understanding of drug dependence: delay discounting processes. Addiction (2001) 6.18
Damage to the insula disrupts addiction to cigarette smoking. Science (2007) 6.11
Measures of impulsivity in cigarette smokers and non-smokers. Psychopharmacology (Berl) (1999) 5.95
Impulsivity as a determinant and consequence of drug use: a review of underlying processes. Addict Biol (2008) 5.67
Time discounting for primary rewards. J Neurosci (2007) 4.76
Impulsivity and rapid discounting of delayed hypothetical rewards in cocaine-dependent individuals. Exp Clin Psychopharmacol (2003) 4.18
Structural abnormalities in the brains of human subjects who use methamphetamine. J Neurosci (2004) 4.14
Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry (2001) 4.13
Delay discounting of money and alcohol in actively using alcoholics, currently abstinent alcoholics, and controls. Psychopharmacology (Berl) (2001) 3.78
The role of impulsive behavior in drug abuse. Psychopharmacology (Berl) (2008) 3.74
Neurocognitive effects of methamphetamine: a critical review and meta-analysis. Neuropsychol Rev (2007) 3.57
Time-dependent increases in brain-derived neurotrophic factor protein levels within the mesolimbic dopamine system after withdrawal from cocaine: implications for incubation of cocaine craving. J Neurosci (2003) 3.30
The hidden island of addiction: the insula. Trends Neurosci (2008) 3.28
Decreased gray matter concentration in the insular, orbitofrontal, cingulate, and temporal cortices of cocaine patients. Biol Psychiatry (2002) 3.22
The cognitive control network: Integrated cortical regions with dissociable functions. Neuroimage (2007) 3.19
Neural activation patterns of methamphetamine-dependent subjects during decision making predict relapse. Arch Gen Psychiatry (2005) 3.03
Central amygdala ERK signaling pathway is critical to incubation of cocaine craving. Nat Neurosci (2005) 2.90
Methamphetamine toxicity and messengers of death. Brain Res Rev (2009) 2.69
Neurobiology of decision making: a selective review from a neurocognitive and clinical perspective. Biol Psychiatry (2005) 2.55
Dissociable neural representations of future reward magnitude and delay during temporal discounting. Neuroimage (2008) 2.52
Effects of methamphetamine dependence and HIV infection on cerebral morphology. Am J Psychiatry (2005) 2.34
Differences between smokers and nonsmokers in regional gray matter volumes and densities. Biol Psychiatry (2004) 2.20
Frontoparietal cortical activity of methamphetamine-dependent and comparison subjects performing a delay discounting task. Hum Brain Mapp (2007) 2.11
Effects of stimulant medication on growth rates across 3 years in the MTA follow-up. J Am Acad Child Adolesc Psychiatry (2007) 2.03
Methamphetamine causes microglial activation in the brains of human abusers. J Neurosci (2008) 1.96
Brain serotonin transporter density and aggression in abstinent methamphetamine abusers. Arch Gen Psychiatry (2006) 1.93
Time and decision making: differential contribution of the posterior insular cortex and the striatum during a delay discounting task. Exp Brain Res (2007) 1.91
Inactivation of the interoceptive insula disrupts drug craving and malaise induced by lithium. Science (2007) 1.88
Lesions of the basolateral amygdala abolish the ability of drug associated cues to reinstate responding during withdrawal from self-administered cocaine. Behav Brain Res (1997) 1.84
Smoking and structural brain deficits: a volumetric MR investigation. Eur J Neurosci (2006) 1.80
Smaller subcortical volumes and cognitive deficits in children with prenatal methamphetamine exposure. Psychiatry Res (2004) 1.78
Lower diffusion in white matter of children with prenatal methamphetamine exposure. Neurology (2009) 1.76
Enlarged striatum in abstinent methamphetamine abusers: a possible compensatory response. Biol Psychiatry (2005) 1.73
Amphetamine or cocaine limits the ability of later experience to promote structural plasticity in the neocortex and nucleus accumbens. Proc Natl Acad Sci U S A (2003) 1.71
Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress. J Neurosci (1994) 1.68
Cortical activation during delay discounting in abstinent methamphetamine dependent individuals. Psychopharmacology (Berl) (2008) 1.67
Amygdala volume associated with alcohol abuse relapse and craving. Am J Psychiatry (2008) 1.56
Abuse of amphetamines and structural abnormalities in the brain. Ann N Y Acad Sci (2008) 1.54
Microglial activation is a pharmacologically specific marker for the neurotoxic amphetamines. Neurosci Lett (2004) 1.53
Amphetamine neurotoxicity: cause and consequence of oxidative stress. Crit Rev Neurobiol (2005) 1.49
A voxel-based morphometry study of frontal gray matter correlates of impulsivity. Hum Brain Mapp (2009) 1.48
Decreased absolute amygdala volume in cocaine addicts. Neuron (2004) 1.41
Cerebral metabolic dysfunction and impaired vigilance in recently abstinent methamphetamine abusers. Biol Psychiatry (2005) 1.40
Impaired object recognition memory following methamphetamine, but not p-chloroamphetamine- or d-amphetamine-induced neurotoxicity. Neuropsychopharmacology (2005) 1.21
The Experiential Discounting Task is sensitive to cigarette-smoking status and correlates with a measure of delay discounting. Behav Pharmacol (2006) 1.21
Prefrontal grey-matter changes in short-term and long-term abstinent methamphetamine abusers. Int J Neuropsychopharmacol (2005) 1.18
Escalating dose-multiple binge methamphetamine exposure results in degeneration of the neocortex and limbic system in the rat. Exp Neurol (2007) 1.15
Delay discounting correlates with proportional lateral frontal cortex volumes. Biol Psychiatry (2009) 1.15
Stimulant treatment over 5 years: effects on growth. J Am Acad Child Adolesc Psychiatry (2006) 1.13
Systemic and central amygdala injections of the mGluR2/3 agonist LY379268 attenuate the expression of incubation of sucrose craving in rats. Behav Brain Res (2007) 1.11
Enhanced oxidative stress and aberrant mitochondrial biogenesis in human neuroblastoma SH-SY5Y cells during methamphetamine induced apoptosis. Toxicol Appl Pharmacol (2007) 1.10
Cerebrovascular complications of methamphetamine abuse. Neurocrit Care (2009) 1.09
Methamphetamine-induced neural and cognitive changes in rodents. Addiction (2007) 0.99
Methodological considerations in the study of delay discounting in intertemporal choice: A comparison of tasks and modes. Behav Res Methods (2008) 0.95
Findings of preserved implicit attention in methamphetamine dependent subjects. Prog Neuropsychopharmacol Biol Psychiatry (2007) 0.86
Understanding the construct of impulsivity and its relationship to alcohol use disorders. Addict Biol (2010) 3.13
Neuropsychological function and delay discounting in methamphetamine-dependent individuals. Psychopharmacology (Berl) (2006) 2.09
Behavioral and biological indicators of impulsivity in the development of alcohol use, problems, and disorders. Alcohol Clin Exp Res (2010) 1.87
Cortical activation during delay discounting in abstinent methamphetamine dependent individuals. Psychopharmacology (Berl) (2008) 1.67
Delay discounting behavior and white matter microstructure abnormalities in youth with a family history of alcoholism. Alcohol Clin Exp Res (2010) 1.49
Mouse lines selected for alcohol consumption differ on certain measures of impulsivity. Alcohol Clin Exp Res (2007) 1.27
Impact of strain and D-amphetamine on impulsivity (delay discounting) in inbred mice. Psychopharmacology (Berl) (2006) 1.26
Optimization of a pyrazolo[1,5-a]pyrimidine class of KDR kinase inhibitors: improvements in physical properties enhance cellular activity and pharmacokinetics. Bioorg Med Chem Lett (2002) 1.23
Synthesis and initial SAR studies of 3,6-disubstituted pyrazolo[1,5-a]pyrimidines: a new class of KDR kinase inhibitors. Bioorg Med Chem Lett (2002) 1.22
Methamphetamine causes persistent immune dysregulation: a cross-species, translational report. Neurotox Res (2010) 1.09
Reward circuit connectivity relates to delay discounting in children with attention-deficit/hyperactivity disorder. Eur Neuropsychopharmacol (2012) 1.07
Strain differences in behavioral inhibition in a Go/No-go task demonstrated using 15 inbred mouse strains. Alcohol Clin Exp Res (2010) 1.04
Delay discounting of reward in ADHD: application in young children. J Child Psychol Psychiatry (2010) 1.03
Mind-body practices: an alternative, drug-free treatment for smoking cessation? A systematic review of the literature. Drug Alcohol Depend (2013) 0.96
The niacin skin flush abnormality in schizophrenia: a quantitative dose-response study. Schizophr Res (2003) 0.96
Discounting of delayed rewards and executive dysfunction in individuals infected with hepatitis C. J Clin Exp Neuropsychol (2010) 0.93
Dopamine D2 receptors mediate reversal learning in male C57BL/6J mice. Cogn Affect Behav Neurosci (2006) 0.91
Behavioral inhibition in mice bred for high vs. low levels of methamphetamine consumption or sensitization. Psychopharmacology (Berl) (2012) 0.89
Acute ethanol does not always affect delay discounting in rats selected to prefer or avoid ethanol. Alcohol Alcohol (2012) 0.89
Risk, reward, and economic decision making in aging. J Gerontol B Psychol Sci Soc Sci (2011) 0.87
Kinesin spindle protein (KSP) inhibitors. Part 2: the design, synthesis, and characterization of 2,4-diaryl-2,5-dihydropyrrole inhibitors of the mitotic kinesin KSP. Bioorg Med Chem Lett (2006) 0.86
The discovery of N-(1,3-thiazol-2-yl)pyridin-2-amines as potent inhibitors of KDR kinase. Bioorg Med Chem Lett (2004) 0.85
Hepatitis C testing and infection rates in bipolar patients with and without comorbid substance use disorders. Bipolar Disord (2008) 0.84
Kinesin spindle protein (KSP) inhibitors. Part 3: synthesis and evaluation of phenolic 2,4-diaryl-2,5-dihydropyrroles with reduced hERG binding and employment of a phosphate prodrug strategy for aqueous solubility. Bioorg Med Chem Lett (2006) 0.83
Strategies to decrease costs of prescribing selective serotonin reuptake inhibitors at a VA Medical Center. Psychiatr Serv (2003) 0.83
Clinical outcomes of integrated psychiatric and general medical care. Community Ment Health J (2007) 0.82
Acute ethanol administration and reinforcer magnitude reduction both reduce responding and increase response latency in a go/no-go task. Alcohol Clin Exp Res (2012) 0.82
Niacin sensitivity and the arachidonic acid pathway in schizophrenia. Schizophr Res (2010) 0.81
Gender differences in factors associated with alcohol drinking: delay discounting and perception of others' drinking. Drug Alcohol Depend (2011) 0.81
The role of antipsychotics in smoking and smoking cessation. CNS Drugs (2011) 0.81
Response bias is unaffected by delay length in a delay discounting paradigm. Behav Processes (2010) 0.80
Mice bred for severity of acute alcohol withdrawal respond differently in a go/no-go task. Alcohol Clin Exp Res (2013) 0.79
Optimization of the indolyl quinolinone class of KDR (VEGFR-2) kinase inhibitors: effects of 5-amido- and 5-sulphonamido-indolyl groups on pharmacokinetics and hERG binding. Bioorg Med Chem Lett (2004) 0.78
Sensitivity to reinforcer delay predicts ethanol's suppressant effects, but itself is unaffected by ethanol. Drug Alcohol Depend (2013) 0.77
Corticotropin releasing factor-1 receptor antagonism alters the biochemical, but not behavioral effects of repeated interleukin-1β administration. Neuropharmacology (2011) 0.77
Basolateral amygdala lesions and sensitivity to reinforcer magnitude in concurrent chains schedules. Behav Brain Res (2008) 0.76
Property-based design of KDR kinase inhibitors. Curr Med Chem (2004) 0.76
Nonpeptide alpha(v)beta(3) antagonists. Part 2: constrained glycyl amides derived from the RGD tripeptide. Bioorg Med Chem Lett (2002) 0.76
Discovery and evaluation of 3-(5-thien-3-ylpyridin-3-yl)-1H-indoles as a novel class of KDR kinase inhibitors. Bioorg Med Chem Lett (2003) 0.75
Non-peptide alpha(v)beta(3) antagonists. Part 3: identification of potent RGD mimetics incorporating novel beta-amino acids as aspartic acid replacements. Bioorg Med Chem Lett (2002) 0.75